WM
WS Management’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-18,876
| Closed | -$1.18M | – | 41 |
|
2023
Q4 | $1.18M | Hold |
18,876
| – | – | 0.07% | 36 |
|
2023
Q3 | $857K | Hold |
18,876
| – | – | 0.07% | 37 |
|
2023
Q2 | $1.06M | Hold |
18,876
| – | – | 0.09% | 36 |
|
2023
Q1 | $854K | Hold |
18,876
| – | – | 0.09% | 37 |
|
2022
Q4 | $767K | Hold |
18,876
| – | – | 0.07% | 39 |
|
2022
Q3 | $1.23M | Hold |
18,876
| – | – | 0.11% | 34 |
|
2022
Q2 | $1.15M | Hold |
18,876
| – | – | 0.09% | 40 |
|
2022
Q1 | $1.19M | Hold |
18,876
| – | – | 0.06% | 41 |
|
2021
Q4 | $1.43M | Hold |
18,876
| – | – | 0.11% | 39 |
|
2021
Q3 | $2.11M | Hold |
18,876
| – | – | 0.22% | 39 |
|
2021
Q2 | $3.06M | Hold |
18,876
| – | – | 0.3% | 42 |
|
2021
Q1 | $2.3M | Sell |
18,876
-964
| -5% | -$117K | 0.24% | 44 |
|
2020
Q4 | $3.04M | Hold |
19,840
| – | – | 0.32% | 30 |
|
2020
Q3 | $1.66M | Hold |
19,840
| – | – | 0.18% | 40 |
|
2020
Q2 | $1.46M | Sell |
19,840
-3,412
| -15% | -$251K | 0.18% | 37 |
|
2020
Q1 | $986K | Sell |
23,252
-1,168
| -5% | -$49.5K | 0.11% | 42 |
|
2019
Q4 | $1.49M | Hold |
24,420
| – | – | 0.13% | 42 |
|
2019
Q3 | $1M | Sell |
24,420
-2,692
| -10% | -$110K | 0.08% | 44 |
|
2019
Q2 | $1.28M | Sell |
27,112
-3,204
| -11% | -$151K | 0.08% | 48 |
|
2019
Q1 | $1.08M | Sell |
30,316
-4,081
| -12% | -$146K | 0.07% | 55 |
|
2018
Q4 | $983K | Sell |
34,397
-22,603
| -40% | -$646K | 0.05% | 67 |
|
2018
Q3 | $2.53M | Hold |
57,000
| – | – | 0.08% | 66 |
|
2018
Q2 | $3.35M | Buy |
+57,000
| New | +$3.35M | 0.09% | 60 |
|